ISRCTN29868352
Completed
Phase 2
A phase II randomised controlled trial assessing the feasibility, acceptability and potential effectiveness of Dignity Therapy for people with advanced cancer
King's College London (UK)0 sites40 target enrollmentFebruary 12, 2009
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Advanced cancer
- Sponsor
- King's College London (UK)
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adults aged greater than or equal to 18 years, either sex, with advanced cancer who have been referred to a hospital\-based palliative care team. In one hospital trust only patients being cared for in the community will be included. In the other hospital only in\-patients and those visiting out\-patient clinics will be included. Participants will not be screened for spiritual or psychological distress, or loss of dignity, however, they will be assessed at baseline, to explore the potential moderating effects of these on the impact of the intervention.
Exclusion Criteria
- •1\. Patients who are considered by the palliative care team to be too ill to take part in a protocol lasting two weeks
- •2\. Unable to provide informed consent either due to cognitive problems, or to the severity of their illness, or because they are unable to understand English
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
An exploratory study of dignity therapy for older people in care homesISRCTN37589515King's College London (UK)64
Recruiting
Phase 2
Dose escalation trial for squamous cell carcinoma of head and neck using FMISO PET CTHealth Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynxCTRI/2024/04/065373Varian Medical Systems Inc
Completed
Not Applicable
Enhancing decision-making about treatment in bipolar II disorder: Evaluation of a treatment decision-aid for patients and their family.Bipolar II disorderMental Health - Other mental health disordersACTRN12617000840381A/Prof Ilona Juraskova196
Not yet recruiting
Phase 2
The effects of novel medicinal cannabis formulation IHL-42X on apnoea hypopnea index in adults with suspected or diagnosed mild to moderate obstructive sleep apnoea.ACTRN12619001103156Cannvalate30
Active, not recruiting
Not Applicable
Clinical trial to determinate viral load in seminal fluid in HIV-positive patients without previous treatmentHIV-1 infectionMedDRA version: 17.1Level: LLTClassification code 10068341Term: HIV-1 infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 17.1Level: PTClassification code 10020161Term: HIV infectionSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2014-001348-39-ESFundación pública andaluza para la gestión de la investigación en salud de Sevilla (FISEVI)